199 related articles for article (PubMed ID: 36347526)
1. Deep learning identifies explainable reasoning paths of mechanism of action for drug repurposing from multilayer biological network.
Yang J; Li Z; Wu WKK; Yu S; Xu Z; Chu Q; Zhang Q
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36347526
[TBL] [Abstract][Full Text] [Related]
2. Machine and deep learning approaches for cancer drug repurposing.
Issa NT; Stathias V; Schürer S; Dakshanamurthy S
Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
[TBL] [Abstract][Full Text] [Related]
3. Application of artificial intelligence and machine learning in drug repurposing.
Ghandikota SK; Jegga AG
Prog Mol Biol Transl Sci; 2024; 205():171-211. PubMed ID: 38789178
[TBL] [Abstract][Full Text] [Related]
4. A geometric deep learning framework for drug repositioning over heterogeneous information networks.
Zhao BW; Su XR; Hu PW; Ma YP; Zhou X; Hu L
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36125202
[TBL] [Abstract][Full Text] [Related]
5. Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening-based approaches.
Ahmed F; Kang IS; Kim KH; Asif A; Rahim CSA; Samantasinghar A; Memon FH; Choi KH
J Med Virol; 2023 Apr; 95(4):e28693. PubMed ID: 36946499
[TBL] [Abstract][Full Text] [Related]
6. Deep fusion learning facilitates anatomical therapeutic chemical recognition in drug repurposing and discovery.
Wang X; Liu M; Zhang Y; He S; Qin C; Li Y; Lu T
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34368838
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive review of artificial intelligence and network based approaches to drug repurposing in Covid-19.
Ahmed F; Soomro AM; Chethikkattuveli Salih AR; Samantasinghar A; Asif A; Kang IS; Choi KH
Biomed Pharmacother; 2022 Sep; 153():113350. PubMed ID: 35777222
[TBL] [Abstract][Full Text] [Related]
8. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
Zhao K; So HC
Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
[TBL] [Abstract][Full Text] [Related]
9. Predicting drug-target interaction network using deep learning model.
You J; McLeod RD; Hu P
Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
[TBL] [Abstract][Full Text] [Related]
10. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
Kashyap K; Siddiqi MI
Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
[TBL] [Abstract][Full Text] [Related]
11. BindingSite-AugmentedDTA: enabling a next-generation pipeline for interpretable prediction models in drug repurposing.
Yousefi N; Yazdani-Jahromi M; Tayebi A; Kolanthai E; Neal CJ; Banerjee T; Gosai A; Balasubramanian G; Seal S; Ozmen Garibay O
Brief Bioinform; 2023 May; 24(3):. PubMed ID: 37096593
[TBL] [Abstract][Full Text] [Related]
12. Artificial intelligence, machine learning, and drug repurposing in cancer.
Tanoli Z; Vähä-Koskela M; Aittokallio T
Expert Opin Drug Discov; 2021 Sep; 16(9):977-989. PubMed ID: 33543671
[No Abstract] [Full Text] [Related]
13. Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases.
Muller C; Rabal O; Diaz Gonzalez C
Methods Mol Biol; 2022; 2390():383-407. PubMed ID: 34731478
[TBL] [Abstract][Full Text] [Related]
14. Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing.
Lim H; Poleksic A; Yao Y; Tong H; He D; Zhuang L; Meng P; Xie L
PLoS Comput Biol; 2016 Oct; 12(10):e1005135. PubMed ID: 27716836
[TBL] [Abstract][Full Text] [Related]
15. A novel drug repurposing approach for non-small cell lung cancer using deep learning.
Li B; Dai C; Wang L; Deng H; Li Y; Guan Z; Ni H
PLoS One; 2020; 15(6):e0233112. PubMed ID: 32525938
[TBL] [Abstract][Full Text] [Related]
16. Drug Repositioning via Graph Neural Networks: Identifying Novel JAK2 Inhibitors from FDA-Approved Drugs through Molecular Docking and Biological Validation.
Yasir M; Park J; Han ET; Park WS; Han JH; Chun W
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542998
[TBL] [Abstract][Full Text] [Related]
17. Tripartite Network-Based Repurposing Method Using Deep Learning to Compute Similarities for Drug-Target Prediction.
Zong N; Wong RSN; Ngo V
Methods Mol Biol; 2019; 1903():317-328. PubMed ID: 30547451
[TBL] [Abstract][Full Text] [Related]
18. Insights into Computational Drug Repurposing for Neurodegenerative Disease.
Paranjpe MD; Taubes A; Sirota M
Trends Pharmacol Sci; 2019 Aug; 40(8):565-576. PubMed ID: 31326236
[TBL] [Abstract][Full Text] [Related]
19. Computationally repurposing drugs for breast cancer subtypes using a network-based approach.
Firoozbakht F; Rezaeian I; Rueda L; Ngom A
BMC Bioinformatics; 2022 Apr; 23(1):143. PubMed ID: 35443626
[TBL] [Abstract][Full Text] [Related]
20. KGML-xDTD: a knowledge graph-based machine learning framework for drug treatment prediction and mechanism description.
Ma C; Zhou Z; Liu H; Koslicki D
Gigascience; 2022 Dec; 12():. PubMed ID: 37602759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
